Holly Hall

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Germany

Consulting Services

Hospital-Pharmacy-Insurance Journal Manuscript Data Science-Bioinformatics IT-Web-Mobile Technology

Areas Of Interest

Huckleberries Preference Misdiagnoses Inbred Mouse Strain Child, Foster Animal Technicians Mastectomies, Extended Radical DNA Library Ethics, Institutional Oxygenation, Hyperbaric Campath-1 Receptor IFN-alphaR Cavernous Hemangiomas, Extracerebral Free-Standing Birthing Centers Pentaerythritol Tetranicotinate Management Systems, Obesity Protein beta Aspartate Methyltransferase Opioid Receptors, kappa Gonadotropin Receptors Caffey Disease Monomesylate, Dihydroergocornine Absorptions, Intracutaneous BR3 B-Cell Activation Factor Receptor Methionine-Specific tRNAm Sulfurous Anhydride X-Ray Absorptiometry, Dual-Energy Transitions, Sol-Gel Phase Nutrition Physiology, Aged Liver Flukes Moraxella kingii Sphingosine Phosphorylcholine Receptors Hyalohyphomycoses, Splenic Cultural Evolution Aspartic Acid, Monosodium Salt Cardiogenic Syncopes ACL Injury

Professional Narrative

Dr. Holly Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Harvard Med 1987
Medical Writer, Amgen 2000

Education

Director Medicine, Weill Medical College 2016
Bachelor of science in nursing, Yale School of Medicine 2008

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02